The techniques available for automated patch clamping are divided into three categories: the automated glass pipette-based patch clamp, the micro-fabricated planar electrode-based patch clamp, and automated TEVC on Xenopus oocytes. The use of automated patch clamp system has increased significantly to perform cardiac safety screening. For instance, automated patch clamp systems such as IonFlux Mercury HT manufactured by Fluxion Biosciences have been used for cardiac safety profiling (hERG).

Market players are focusing on launching advanced automated patch clamp systems, in order to strengthen their market presence and expand their product portfolio, which is expected to boost growth of the global automated patch clamp system market over the forecast period. For instance, in September 2020, Fluxion Biosciences launched IonFlux Mercury Ultra, a high-throughput automated patch clamp system.

Market Dynamics

Increasing research and development of therapeutic drugs and medical devices is expected to drive growth of the automated patch clamp system market over the forecast period. According to the United Nations Educational, Scientific and Cultural Organization (UNESCO), November 2016, an estimated US$ 1.7 trillion was spent on research and development for various medical applications, globally. Moreover, the U.S. Food and Drug Administration (FDA) and its Center for Drug Evaluation and Research (CDER) approved around 59 novel drugs in 2018 compared to 46 approvals of new molecule entities in 2017.

Moreover, according to the Pharma R&D Annual Review, 2019, an estimated number of drugs under pipeline in 2019 was around 16,181, while in 2018, it was around 15,267, resulting in an overall pipeline growth by 6% in 2018.

Key features of the study

• This report provides in-depth analysis of the global automated patch clamp system market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global automated patch clamp system market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Sophion Bioscience A/S, Nanion Technologies GmbH, NeoBiosystems, Inc., Multi Channel Systems MCS GmbH, Fluxion Biosciences, Molecular Devices, LLC, Scitech Korea Inc., and HEKA Elektronik GmbH
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global automated patch clamp system market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global automated patch clamp system market

Automated Patch Clamp System Market Segmentation

• By Technique
  • Automated Glass Pipette-based Patch Clamp
  • Micro-fabricated Planar Electrode-based Patch Clamp
  • Automated TEVC On Xenopus Oocytes
• By Amplifiers
  • 8
  • 16
  • 384
  • 768
  • Others
• By End User
  • Contract Research Organization
  • Biopharmaceuticals
  • Academic & Research Institutes
• Global Automated Patch Clamp System Market, By Region: (Revenue, USD Mn, 2021-2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
• Key Players
  • Sophion Bioscience A/S
  • Nanion Technologies GmbH
  • NeoBiosystems, Inc.
  • Multi-Channel Systems MCS GmbH
  • Fluxion Biosciences
  • Molecular Devices, LLC
  • Scitech Korea Inc.
  • HEKA Elektronik GmbH